Valuation: Recordati

Capitalization 11.28B 13.04B 10.61B 9.61B 17.7B 1,119B 20B 124B 48.18B 515B 48.94B 47.89B 1,888B P/E ratio 2025 *
23.4x
P/E ratio 2026 * 20x
Enterprise value 13.08B 15.12B 12.3B 11.14B 20.52B 1,297B 23.19B 143B 55.86B 597B 56.75B 55.53B 2,189B EV / Sales 2025 *
4.95x
EV / Sales 2026 * 4.55x
Free-Float
46.81%
Yield 2025 *
2.76%
Yield 2026 * 3.05%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.64%
1 week-0.45%
Current month+3.60%
1 month+7.05%
3 months+3.80%
6 months+8.00%
Current year+8.10%
More quotes
1 week 53.95
Extreme 53.95
55.35
1 month 50.5
Extreme 50.5
55.35
Current year 43.98
Extreme 43.98
60.95
1 year 43.98
Extreme 43.98
60.95
3 years 34.52
Extreme 34.52
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 18.1
Extreme 18.1
60.95
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 2021-11-30
Director of Finance/CFO 55 2019-10-31
Chief Tech/Sci/R&D Officer - 2017-06-30
Director TitleAgeSince
Chairman 53 2021-11-30
Director/Board Member 54 2014-04-16
Chairman 56 2018-06-11
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.64%-0.45%+13.72%+44.63% 12.96B
-1.44%+4.90%-8.07%+175.63% 736B
-1.20%+0.12%+6.65%-8.69% 378B
-0.12%+0.54%+13.21%+38.21% 338B
-2.52%-1.98%+6.18%-14.57% 266B
-0.81%-0.73%+1.43%+18.89% 235B
-1.53%+0.33%-13.53%+9.76% 232B
+0.07%+2.52%-37.47%-4.34% 205B
+0.12%+1.80%-1.02%+25.46% 159B
-0.57%+4.50%-11.37%-49.70% 140B
Average -0.54%+2.01%-3.03%+23.53% 270.01B
Weighted average by Cap. -0.51%+2.87%-3.47%+51.26%
See all sector performances

Financials

2025 *2026 *
Net sales 2.64B 3.06B 2.49B 2.25B 4.15B 262B 4.69B 28.98B 11.29B 121B 11.47B 11.22B 442B 2.82B 3.26B 2.65B 2.4B 4.42B 279B 4.99B 30.87B 12.02B 128B 12.21B 11.95B 471B
Net income 510M 590M 480M 434M 800M 50.58B 904M 5.59B 2.18B 23.26B 2.21B 2.17B 85.34B 589M 681M 554M 502M 924M 58.41B 1.04B 6.46B 2.51B 26.86B 2.55B 2.5B 98.53B
Net Debt 1.8B 2.08B 1.69B 1.53B 2.82B 178B 3.19B 19.72B 7.68B 82.03B 7.8B 7.64B 301B 1.52B 1.76B 1.43B 1.29B 2.38B 151B 2.69B 16.65B 6.49B 69.27B 6.59B 6.45B 254B
More financial data * Estimated data
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (65.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (34.3%). Net sales are distributed geographically as follows: Italy (15.2%), Europe (56.4%), America (19%), Asia and Oceania (6.7%) and Africa (2.7%).
Employees
4,539
More about the company
Date Price Change Volume
25-06-16 54.70 +0.64% 201,163
25-06-13 54.35 -1.72% 244,203
25-06-12 55.30 +0.09% 185,342
25-06-11 55.25 +0.27% 252,518
25-06-10 55.10 +1.19% 249,170

Real-time Borsa Italiana, June 16, 2025 at 11:45 am

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
54.35EUR
Average target price
59.22EUR
Spread / Average Target
+8.96%
Consensus

Quarterly revenue - Rate of surprise